Bon‐Hyeock Koo

Arginase II activity regulates cytosolic Ca2+ level in a p32-dependent manner that contributes to Ca2+-dependent vasoconstriction in native low-density lipoprotein-stimulated vascular smooth muscle cells

Bon‐Hyeock Koo, Dongeui Hong, Hyeon Hong et al. · Experimental & Molecular Medicine · 2019 · 33 citations · Full text

Life Sciences, Pharmacology, Physiology +17

2′–5′ oligoadenylate synthetase‑like 1 (OASL1) protects against atherosclerosis by maintaining endothelial nitric oxide synthase mRNA stability

Tae Kyeong Kim, Sejin Jeon, Seonjun Park et al. · Nature Communications · 2022 · 30 citations · Full text

Life Sciences, Cardiology, Molecular Biology +16

Arginase II Contributes to the Ca ²⁺ /CaMKII/eNOS Axis by Regulating Ca ²⁺ Concentration Between the Cytosol and Mitochondria in a p32‐Dependent Manner

Bon‐Hyeock Koo, Hye‐Mi Hwang, Bong‐Gu Yi et al. · Journal of the American Heart Association · 2018 · 22 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cells

Bon‐Hyeock Koo, Moo‐Ho Won, Young‐Myeong Kim et al. · Cardiovascular Research · 2021 · 19 citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

Arginase II inhibition prevents interleukin-8 production through regulation of p38 MAPK phosphorylation activated by loss of mitochondrial membrane potential in nLDL-stimulated hAoSMCs

Bon‐Hyeock Koo, Bong-Gu Yi, Myeong-Seon Jeong et al. · Experimental & Molecular Medicine · 2018 · 17 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16